Safety of short-term use of dabigatran or rivaroxaban for direct-current cardioversion in patients with atrial fibrillation and atrial flutter

Ajay Yadlapati*, Christopher Groh, Rod S Passman

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

36 Scopus citations

Fingerprint

Dive into the research topics of 'Safety of short-term use of dabigatran or rivaroxaban for direct-current cardioversion in patients with atrial fibrillation and atrial flutter'. Together they form a unique fingerprint.

INIS

Pharmacology, Toxicology and Pharmaceutical Science